ID   PLPL7_RAT               Reviewed;        1349 AA.
AC   Q5BK26; Q5XIX2; Q8K3H9;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   02-OCT-2024, entry version 113.
DE   RecName: Full=Patatin-like phospholipase domain-containing protein 7;
DE            EC=3.1.1.- {ECO:0000269|PubMed:12893290};
DE            EC=3.1.1.5 {ECO:0000250|UniProtKB:A2AJ88};
DE   AltName: Full=Liver NTE-related protein 1;
DE   AltName: Full=NTE-related esterase;
GN   Name=Pnpla7; Synonyms=Nre, Ntel1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 668-1349, CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF SER-980.
RC   TISSUE=Brain, and Liver;
RX   PubMed=12893290; DOI=10.1016/s0003-9861(03)00264-9;
RA   Xie M., Yang D., Matoney L., Yan B.;
RT   "Rat NTE-related esterase is a membrane-associated protein, hydrolyzes
RT   phenyl valerate, and interacts with diisopropylfluorophosphate through a
RT   serine catalytic machinery.";
RL   Arch. Biochem. Biophys. 416:137-146(2003).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; SER-1277 AND THR-1281,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Lysophospholipase which preferentially deacylates unsaturated
CC       lysophosphatidylcholine (C18:1), generating glycerophosphocholine. Also
CC       can deacylate, to a lesser extent, lysophosphatidylethanolamine
CC       (C18:1), lysophosphatidyl-L-serine (C18:1) and lysophosphatidic acid
CC       (C16:0). {ECO:0000250|UniProtKB:A2AJ88}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + H2O = a fatty acid +
CC         H(+) + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:15177,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16870,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:58168; EC=3.1.1.5;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15178;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H2O = (9Z)-
CC         octadecenoate + H(+) + sn-glycerol 3-phosphocholine;
CC         Xref=Rhea:RHEA:40807, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16870, ChEBI:CHEBI:28610, ChEBI:CHEBI:30823;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40808;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine + H2O =
CC         (9Z)-octadecenoate + H(+) + sn-glycero-3-phosphoethanolamine;
CC         Xref=Rhea:RHEA:40895, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:74971, ChEBI:CHEBI:143890;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40896;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-serine + H2O =
CC         (9Z)-octadecenoate + H(+) + sn-glycero-3-phospho-L-serine;
CC         Xref=Rhea:RHEA:40499, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:64765, ChEBI:CHEBI:74617;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40500;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:40435,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16870, ChEBI:CHEBI:72998;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40436;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphate + H2O = H(+) +
CC         hexadecanoate + sn-glycerol 3-phosphate; Xref=Rhea:RHEA:49092,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57518, ChEBI:CHEBI:57597;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49093;
CC         Evidence={ECO:0000250|UniProtKB:A2AJ88};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A2AJ88}; Single-pass type III membrane protein
CC       {ECO:0000250|UniProtKB:A2AJ88}. Lipid droplet
CC       {ECO:0000250|UniProtKB:A2AJ88}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, liver, kidney, lung and
CC       testis. {ECO:0000269|PubMed:12893290}.
CC   -!- DOMAIN: The 3 cNMP binding domains are required for localization to the
CC       endoplasmic reticulum. The cNMP binding domain 3 is involved in the
CC       binding to lipid droplets. {ECO:0000250|UniProtKB:A2AJ88}.
CC   -!- SIMILARITY: Belongs to the NTE family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-27 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH91230.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC083547; AAH83547.2; -; mRNA.
DR   EMBL; BC091230; AAH91230.1; ALT_INIT; mRNA.
DR   EMBL; AY100477; AAM44077.1; -; mRNA.
DR   RefSeq; NP_653339.2; NM_144738.2.
DR   AlphaFoldDB; Q5BK26; -.
DR   SMR; Q5BK26; -.
DR   STRING; 10116.ENSRNOP00000011633; -.
DR   iPTMnet; Q5BK26; -.
DR   PhosphoSitePlus; Q5BK26; -.
DR   jPOST; Q5BK26; -.
DR   PaxDb; 10116-ENSRNOP00000011633; -.
DR   GeneID; 246246; -.
DR   KEGG; rno:246246; -.
DR   UCSC; RGD:708466; rat.
DR   AGR; RGD:708466; -.
DR   CTD; 375775; -.
DR   RGD; 708466; Pnpla7.
DR   eggNOG; KOG2968; Eukaryota.
DR   InParanoid; Q5BK26; -.
DR   OrthoDB; 5303733at2759; -.
DR   PhylomeDB; Q5BK26; -.
DR   PRO; PR:Q5BK26; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; ISS:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; ISS:UniProtKB.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; ISS:UniProtKB.
DR   CDD; cd00038; CAP_ED; 3.
DR   CDD; cd07225; Pat_PNPLA6_PNPLA7; 1.
DR   Gene3D; 3.40.1090.10; Cytosolic phospholipase A2 catalytic domain; 1.
DR   Gene3D; 2.60.120.10; Jelly Rolls; 3.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR018490; cNMP-bd_dom_sf.
DR   InterPro; IPR050301; NTE.
DR   InterPro; IPR002641; PNPLA_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR14226; NEUROPATHY TARGET ESTERASE/SWISS CHEESE D.MELANOGASTER; 1.
DR   PANTHER; PTHR14226:SF23; PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 7; 1.
DR   Pfam; PF00027; cNMP_binding; 3.
DR   Pfam; PF01734; Patatin; 1.
DR   SMART; SM00100; cNMP; 3.
DR   SUPFAM; SSF51206; cAMP-binding domain-like; 3.
DR   SUPFAM; SSF52151; FabD/lysophospholipase-like; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 3.
DR   PROSITE; PS51635; PNPLA; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Hydrolase; Lipid degradation; Lipid droplet;
KW   Lipid metabolism; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..1349
FT                   /note="Patatin-like phospholipase domain-containing protein
FT                   7"
FT                   /id="PRO_0000293491"
FT   TOPO_DOM        1..36
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        37..57
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        58..1349
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          947..1113
FT                   /note="PNPLA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   REGION          340..361
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          678..964
FT                   /note="Involved in the binding to lipid droplets"
FT                   /evidence="ECO:0000250|UniProtKB:A2AJ88"
FT   REGION          1297..1349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           951..956
FT                   /note="GXGXXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           978..982
FT                   /note="GXSXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           1100..1102
FT                   /note="DGA/G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   COMPBIAS        1300..1336
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        980
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   ACT_SITE        1100
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   BINDING         170..297
FT                   /ligand="a nucleoside 3',5'-cyclic phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58464"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   BINDING         496..599
FT                   /ligand="a nucleoside 3',5'-cyclic phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58464"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   BINDING         610..715
FT                   /ligand="a nucleoside 3',5'-cyclic phosphate"
FT                   /ligand_id="ChEBI:CHEBI:58464"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZV29"
FT   MOD_RES         1277
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1281
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         980
FT                   /note="S->A,C,D,H: Abolishes hydrolytic activity."
FT                   /evidence="ECO:0000269|PubMed:12893290"
FT   CONFLICT        956..957
FT                   /note="GC -> CT (in Ref. 1; AAH91230)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1071
FT                   /note="A -> S (in Ref. 1; AAH83547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1217..1219
FT                   /note="PAG -> RTV (in Ref. 1; AAH83547)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1349 AA;  150024 MW;  4312292A0CFE2FDD CRC64;
     MQKEEDVCPE AGYCLGTALS SWGLHFMEEH SQSTMLMGIG IGVLLTLAFV GLAAFFVYRK
     VSRFRRAEPI PQYRFRKRDK VMFYGRKIMR KVTTLPHTLV GNTAAPRQRV RKRTKVLSLA
     KRILRFKKEY PTLQPKEPPP SLLEADLTEF DVKNSHLPSE VLYMLKNVRV LGHFEKPLFL
     ELCKHMVFVQ LQEGEHVFQP GEPDISIYVV QDGRLEVCIQ DADGTEVVVK EVLPGDSVHS
     LLSILDVITG HTAPYKTVSA RAAVASTVLW LPAAAFQGVF EKYPETLVRV VQIIMVRLQR
     VTFLALHNYL GLTTELFNPE SQAIPLLSVA SVAGRAKRQM SYGPEEQLER SPRLSEFNSS
     DQRSVAVSGP LLKRSCSVPL PPIHGEIDEL RQAQGSGSNT SAFQESQEGA TSDLGMAYNR
     ARILPHSEEQ LGSSLASKSK KSVVAETSAV FHYSEKPRDE PGPSGRTDAI FRAATKDLLT
     LMKLDDPSLL DGRVAFLHVP AGTIVSKQGD QDVNILFVVS GMLHVYQQKI DSLEDTCLFL
     THPGEMVGQL AVLTGEPLMF TIRANRDCSF LSISKAHFYE IMRKRPDVVL GVAHTVVRRM
     SSFVRQIDFA LDWMEVEAGR AIYRQGDKSD CTYIVLSGRL RSVIRKDDGK KRLAGEYGRG
     DLVGVVEMLT HQARATTVHA VRDSELAKLP AGALTSIKRR YPQVVTRLIH LLGEKILGSL
     QQGSGTGHQL GFNTASSKWD LGNPPGNLST VAAMPVSEDV PLTAFALELQ HALSAIGPVL
     LLTSDNIKQR LGSAALDSIH EYRLSSWLGQ QEDIHRIVLY QADSTLTPWT QRCIRQADCI
     LIVGLGDQEP ALGELEQMLE STAVRAQKQL ILLHKEEGPA PSRTVEWLNM RSWCSGHLHL
     CCPRRVFSKR SLPKLVEMYT RIFQRPPDRH SDFSRLARIL TGNAIALVLG GGGARGCAQV
     GILRALAECG IPVDIIGGTS IGAFMGALFA EERSYSQIRI RAKQWAEDMT SMVKTILDLT
     YPITSMFSGT GFNSSISNIF KDRQIEDLWL PYFAITTDIT ASAMRVHTDG ALWRYVRASM
     SLSGYMPPLC DPKDGHLLMD GGYINNLPAD VARSMGAKVV IAIDVGSRDE TDLTNYGDAL
     SGWWLLWKRW NPLATKVKVL NMAEIQTRLA YVCCVRQLEM VKNSDYCEYL RPPIDSYRTL
     DFGKFDEICE VGYQHGPAGF DIWVRSGVLE KMLQDQQGTS KRMDCGVFTC PNSSFTDLAE
     IVSRIEPAKV AAVDDESDYQ TEYEEELPAI PKETYADFQS TGIELDSDSE CEPSMSQGPH
     SLTSPKQSQD SFPWLPNQDD QGPRLYRPS
//
